The study evaluated the performance of targeted next-generation sequencing (tNGS) for detecting drug-resistant tuberculosis (DR-TB) directly from clinical specimens in Bangladesh. tNGS showed high sensitivity and specificity for detecting resistance to rifampicin, isoniazid, fluoroquinolones, and aminoglycosides, making it a promising tool for rapid and comprehensive drug susceptibility testing.